257 related articles for article (PubMed ID: 8520272)
1. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.
Quinn M; Allen E
BMJ; 1995 Nov; 311(7017):1391-5. PubMed ID: 8520272
[TBL] [Abstract][Full Text] [Related]
2. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.
Blanks RG; Moss SM; McGahan CE; Quinn MJ; Babb PJ
BMJ; 2000 Sep; 321(7262):665-9. PubMed ID: 10987769
[TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
[TBL] [Abstract][Full Text] [Related]
4. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
Johns LE; Coleman DA; Swerdlow AJ; Moss SM
Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
[TBL] [Abstract][Full Text] [Related]
5. Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom.
van den Akker-van Marle E; de Koning H; Boer R; van der Maas P
J Med Screen; 1999; 6(1):30-4. PubMed ID: 10321368
[TBL] [Abstract][Full Text] [Related]
6. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
Tabar L; Yen MF; Vitak B; Chen HH; Smith RA; Duffy SW
Lancet; 2003 Apr; 361(9367):1405-10. PubMed ID: 12727392
[TBL] [Abstract][Full Text] [Related]
7. Mammography screening and breast cancer mortality in New South Wales, Australia.
Taylor R; Morrell S; Estoesta J; Brassil A
Cancer Causes Control; 2004 Aug; 15(6):543-50. PubMed ID: 15280633
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening.
Kricker A; Farac K; Smith D; Sweeny A; McCredie M; Armstrong BK
Int J Cancer; 1999 Jun; 81(6):877-80. PubMed ID: 10362133
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994).
Walker JJ; Brewster D; Gould A; Raab GM
Public Health; 1998 Nov; 112(6):373-8. PubMed ID: 9883033
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
11. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales.
Waller M; Moss S; Watson J; Møller H
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2257-61. PubMed ID: 18006913
[TBL] [Abstract][Full Text] [Related]
12. Impact of NHS breast screening on advanced disease and mortality from breast cancer in the North West of England.
Threlfall AG; Collins S; Woodman CB
Br J Cancer; 2003 Jul; 89(1):77-80. PubMed ID: 12838304
[TBL] [Abstract][Full Text] [Related]
13. Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer.
Prior P; Woodman CB; Wilson S; Threlfall AG
J Med Screen; 1996; 3(3):119-22. PubMed ID: 8946305
[TBL] [Abstract][Full Text] [Related]
14. Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.
Bennett RL; Sellars SJ; Moss SM
Br J Cancer; 2011 Feb; 104(4):571-7. PubMed ID: 21285989
[TBL] [Abstract][Full Text] [Related]
15. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
16. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate.
Blanks RG; Day NE; Moss SM
J Med Screen; 1996; 3(2):79-81. PubMed ID: 8849764
[TBL] [Abstract][Full Text] [Related]
18. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
Mukhtar TK; Yeates DR; Goldacre MJ
J R Soc Med; 2013 Jun; 106(6):234-42. PubMed ID: 23761583
[TBL] [Abstract][Full Text] [Related]
20. Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women.
Johns LE; Swerdlow AJ; Moss SM
J Med Screen; 2018 Jun; 25(2):76-81. PubMed ID: 28675954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
